Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancer
Articolo
Data di Pubblicazione:
2019
Citazione:
Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancer / Martini, A; Jia, R; Ferket, Bs; Waingankar, N; Plimack, Er; Crabb, Sj; Harshman, Lc; Yu, Ey; Powles, T; Rosenberg, Je; Pal, Sk; Vaishampayan, Un; Necchi, A; Wiklund, Np; Mehrazin, R; Mazumdar, M; Sfakianos, Jp; Galsky, Md. - In: CANCER. - ISSN 0008-543X. - 125:18(2019), pp. 3155-3163. [10.1002/cncr.32169]
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Martini, A; Jia, R; Ferket, Bs; Waingankar, N; Plimack, Er; Crabb, Sj; Harshman, Lc; Yu, Ey; Powles, T; Rosenberg, Je; Pal, Sk; Vaishampayan, Un; Necchi, A; Wiklund, Np; Mehrazin, R; Mazumdar, M; Sfakianos, Jp; Galsky, Md
Link alla scheda completa:
Pubblicato in: